All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
The ALL Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
An expert panel hosted by
Customizing first-line BTK inhibitors for CLL
with Gilles Salles, Paolo Ghia, and Francesc Bosch
Wednesday, October 23, 2024
18:30-19:30 BST
This independent educational activity is supported by Pharmacyclics LLC, an AbbVie Company and Janssen Biotech. All content is developed independently by the faculty. The funder is allowed no influence on the content of this activity.
The ALL Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the ALL Hub cannot guarantee the accuracy of translated content. The ALL Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The ALL Hub is an independent medical education platform, sponsored by Jazz Pharmaceuticals, Amgen, and Pfizer. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
What are the geographical barriers to accessing specialty cancer care among adolescents and young adults with ALL?
Featured
During the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke with Lori Muffly, Stanford Medicine, Stanford, US. We asked about the geographical barriers to accessing specialty cancer care among adolescents and young adults with ALL.
What are the geographical barriers to accessing specialty cancer care among young adults with ALL?
Muffly discusses the geographical barriers to receiving specialty cancer care among young adolescent patients with ALL. Research was conducted to quantify the distance between patient residences and treatment centers, such as National Cancer Institute designated cancer centers or Children’s Oncology Group sites. She then discusses the results, highlighting long travel times as a significant geographical barrier to accessing care across the U.S. and concluding that more networks and centers are needed.
More about...
Your opinion matters
2 votes - 9 hours left ...
Related articles
Newsletter
Subscribe to get the best content related to ALL delivered to your inbox